Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F D Kolodgie

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Current Opinion in Cardiology|August 22, 2000
Apoptosis and cardiomyopathyJ Narula, F D Kolodgie, R Virmani
Human Pathology|June 1, 1995
Pathobiological determinants of cocaine-associated cardiovascular syndromesF D Kolodgie, A Farb, R Virmani
Circulation Research|August 19, 2000
Local delivery of ceramide for restenosis: is there a future for lipid therapy?F D Kolodgie, A Farb, R Virmani
Journal of the American College of Cardiology|July 1, 1991
Limitation of no reflow injury by blood-free reperfusion with oxygenated perfluorochemical (Fluosol-DA 20%)F D Kolodgie, R Virmani, A Farb
Minerva Cardioangiologica|February 11, 2012
Ex vivo and preclinical assessment of an endothelial progenitor cell capturing bioengineered stentS K Yazdani, F D Kolodgie, R Virmani
Circulation|March 1, 1990
Myocardial reperfusion injury. Histopathological effects of perfluorochemicalR Virmani, M B Forman, F D Kolodgie
Apoptosis : an International Journal on Programmed Cell Death|November 25, 2003
Apoptosis in human atherosclerotic plaquesF D Kolodgie, J Narula, P Guillo, et al.
Cardiology Clinics|January 15, 2002
Apoptosis in atherosclerosis. Does it contribute to plaque instability?F D Kolodgie, J Narula, N Haider, et al.
Heart (British Cardiac Society)|January 16, 2003
Drug eluting stents: are human and animal studies comparable?R Virmani, F D Kolodgie, A Farb, et al.
Journal of the American College of Cardiology|April 1, 1993
Myocardial infarct extension during reperfusion after coronary artery occlusion: pathologic evidenceA Farb, F D Kolodgie, M Jenkins, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Current Opinion in Cardiology|August 22, 2000
Apoptosis and cardiomyopathyJ Narula, F D Kolodgie, R Virmani
Human Pathology|June 1, 1995
Pathobiological determinants of cocaine-associated cardiovascular syndromesF D Kolodgie, A Farb, R Virmani
Circulation Research|August 19, 2000
Local delivery of ceramide for restenosis: is there a future for lipid therapy?F D Kolodgie, A Farb, R Virmani
Journal of the American College of Cardiology|July 1, 1991
Limitation of no reflow injury by blood-free reperfusion with oxygenated perfluorochemical (Fluosol-DA 20%)F D Kolodgie, R Virmani, A Farb
Minerva Cardioangiologica|February 11, 2012
Ex vivo and preclinical assessment of an endothelial progenitor cell capturing bioengineered stentS K Yazdani, F D Kolodgie, R Virmani
Circulation|March 1, 1990
Myocardial reperfusion injury. Histopathological effects of perfluorochemicalR Virmani, M B Forman, F D Kolodgie
Apoptosis : an International Journal on Programmed Cell Death|November 25, 2003
Apoptosis in human atherosclerotic plaquesF D Kolodgie, J Narula, P Guillo, et al.
Cardiology Clinics|January 15, 2002
Apoptosis in atherosclerosis. Does it contribute to plaque instability?F D Kolodgie, J Narula, N Haider, et al.
Heart (British Cardiac Society)|January 16, 2003
Drug eluting stents: are human and animal studies comparable?R Virmani, F D Kolodgie, A Farb, et al.
Journal of the American College of Cardiology|April 1, 1993
Myocardial infarct extension during reperfusion after coronary artery occlusion: pathologic evidenceA Farb, F D Kolodgie, M Jenkins, et al.
Pageof 6